2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0...

181
Verein für Association pour le Associazione per il medizinische Qualitätskontrolle contrôle de qualité médical controllo di qualità medico MQ, Institut für Klinische Chemie, Universitätsspital Zürich, 8091 Zürich Telefon 044/255 34 11, Telefax 044/261 12 83, www.mqzh.ch, [email protected] Survey Report 2015 - 1

Transcript of 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0...

Page 1: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Verein für Association pour le Associazione per il

medizinische Qualitätskontrolle contrôle de qualité médical controllo di qualità medico

MQ, Institut für Klinische Chemie, Universitätsspital Zürich, 8091 Zürich Telefon 044/255 34 11, Telefax 044/261 12 83, www.mqzh.ch, [email protected]

Survey Report

2015 - 1

Page 2: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Survey Specimens The homogeneity and stability of all specimens were checked before and/or during shipment and no irregularities were noted. The suitability tests were performed by the laboratories of the Universitätsspital Zürich (University Hospital Zurich) (http://www.uzl.usz.ch/). The following survey specimens were produced specifically for MQ by a sub-contractor: B1 Strep A Test, B2 Uricult, H4 Parasitic Hematology, K14 tumor marker Determination of target values For each target value, the type of determination per ISO17043: 2010 B2.1 is indicated (column "type"): a Value known due to production. b Certified reference value for use with special specimens c Reference value determined by analysis d Consensus values of expert laboratories e Consensus values of the participants For methods groups with more than 9 participants, consensus values of the participants ("e") are generally determined. In order to provide all participants with target values that are as meaningful as possible, other methods may also be applied for smaller method groups. Uncertainty of the determined target values The standard uncertainty (ux) is calculated using the following formula (ISO13528): ux = (target value/100) * (1.25/square root of "number of participants") * %CV

ux has the same unit as the target value ux can be compared with the standard deviation of the participants' collective (SD=target value*%CV/100) For participant numbers >18, the standard uncertainty (ux) is significantly lower than the scatter of the collective

participants and can be neglected.

QUALAB and MQ tolerances

For all mandatory analyzes, QUALAB tolerances are used (www.qualab.ch, external quality control). For non-mandatory analyzes, the tolerances are specified by MQ's survey specimen leader. If the determined uncertainty, ux, of the target value is greater than 15% of the QUALAB or MQ tolerance, the letter indicating the type of target detection is marked with an additional star (example "e*"). Thereby, we are alerting the participants to the fact that the uncertainty of the target value can have an impact on the evaluation.

Graphics

The results are shown graphically as follows:

lower Qualab limit80% of the results

50% of the results

lowestvalue

target value

highestvalue

upper Qualab limit

Comparison of Devices The data in this report allows you to compare the performance of different devices. However, remember to consider the following: The chemical control K1 is a ready-to-use commercial control serum. Even if the specimen is of human origin, it is possible

that matrix effects occur. These are device-specific and result in different target values. Only one specimen was measured. Since the scatter of the results is dependent on the nature of the specimen (matrix

effects) and on the signal strength, the determined coefficient of variations (CV in %) cannot be applied generally. A large number of runaways is due to administrative errors (wrong unit, results mixed up) or to operator errors (wrong

sample, not correctly taken up in solution, not mixed well) and has nothing to do with the type of device. .

Zürich, 30.3.2015

Dr. R. Fried Suvey Director Publication of this report or any portion thereof without our prior written consent is not permitted. The

original is archived at www.mqzh.ch .

Page 3: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Hemoglobin

H1 Hematology

QUALAB tolerance : 9 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Automat 54 88.8 5.6 5.6 106.0 3.7 e

2 Cyanmethemoglobin 53 92.4 3.8 3.8 105.7 3.5 e

3 Sysmex XT/XE/XS 39 100.0 0.0 0.0 106.7 1.2 e

4 ABX Pentra 11 100.0 0.0 0.0 105.9 2.4 e

5 Reflotron 83 86.8 8.4 4.8 108.9 5.1 e

6 Hemocue 337 95.2 0.9 3.9 105.3 2.6 e

7 Dr. Lange 24 95.8 0.0 4.2 106.7 4.2 e

8 Hemocontrol 12 91.7 0.0 8.3 108.1 1.6 e

9 Eurolyser 5 100.0 0.0 0.0 107.0 3.6 e*

10 Other methods 6 83.3 16.7 0.0 111.0 5.9 e*

90 94 98 102 106 110 114 118 122 126 130

Hemoglobin (g/l)

1

2

3

4

5

6

7

8

9

10

MQ 2015/1 Page 3/181

Page 4: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Hemoglobin

H1 Hematology

QUALAB tolerance : 9 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Abx Micros 917 95.3 1.2 3.5 104 2.9 e

2 Microsemi 202 98.5 0.0 1.5 105 2.1 e

3 Sysmex KX21 446 97.1 0.4 2.5 106 1.9 e

4 Sysmex PocH - 100i 219 96.8 0.9 2.3 104 2.5 e

5 Sysmex XP 300 148 98.6 0.0 1.4 108 1.6 e

6 Mythic 244 95.9 0.8 3.3 101 3.6 e

7 Swelab 68 95.6 1.5 2.9 108 2.8 e

8 MS4 8 100.0 0.0 0.0 102 4.5 e*

9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e

10 Medonic 19 100.0 0.0 0.0 106 3.8 e

11 Nihon Kohden Celltac 34 97.1 0.0 2.9 104 2.9 e

12 Samsung HC10 42 97.6 0.0 2.4 104 3.0 e

85 89 93 97 101 105 109 113 117 121 125

Hemoglobin (g/l)

1

2

3

4

5

6

7

8

9

10

11

12

MQ 2015/1 Page 4/181

Page 5: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Hematocrit

H1 Hematology

QUALAB tolerance : 9 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Automat 47 70.2 21.3 8.5 0.30 6.8 e

2 Centrifuge 16 87.5 12.5 0.0 0.31 5.3 e*

3 Sysmex XT/XE/XS 38 100.0 0.0 0.0 0.30 2.1 e

4 ABX Pentra 11 100.0 0.0 0.0 0.28 3.5 e

0.240 0.251 0.262 0.273 0.284 0.295 0.306 0.317 0.328 0.339 0.350

Hematocrit (l/l)

1

2

3

4

MQ 2015/1 Page 5/181

Page 6: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Hematocrit

H1 Hematology

QUALAB tolerance : 9 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Abx Micros 918 91.2 3.9 4.9 0.28 4.2 e

2 Microsemi 201 98.0 1.0 1.0 0.28 2.5 e

3 Sysmex KX21 446 96.9 1.3 1.8 0.28 2.5 e

4 Sysmex PocH - 100i 219 95.4 0.9 3.7 0.30 2.9 e

5 Sysmex XP 300 144 98.6 0.0 1.4 0.28 1.7 e

6 Mythic 244 95.5 2.5 2.0 0.29 4.0 e

7 Swelab 68 92.7 2.9 4.4 0.29 3.8 e

8 MS4 8 75.0 25.0 0.0 0.28 6.6 e*

9 Abacus Junior 12 91.7 8.3 0.0 0.31 4.4 e*

10 Medonic 19 94.7 0.0 5.3 0.29 3.4 e

11 Nihon Kohden Celltac 34 97.1 0.0 2.9 0.29 2.7 e

12 Samsung HC10 42 97.6 0.0 2.4 0.31 3.1 e

0.230 0.242 0.254 0.266 0.278 0.290 0.302 0.314 0.326 0.338 0.350

Hematocrit (l/l)

1

2

3

4

5

6

7

8

9

10

11

12

MQ 2015/1 Page 6/181

Page 7: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Erythrocytes

H1 Hematology

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Automat 46 97.8 2.2 0.0 3.45 6.9 e

2 Microscopic 9 100.0 0.0 0.0 3.20 13.9 e*

3 Sysmex XT/XE/XS 39 100.0 0.0 0.0 3.42 1.7 e

4 ABX Pentra 11 100.0 0.0 0.0 3.42 2.3 e

2.0 2.3 2.6 2.9 3.2 3.5 3.8 4.1 4.4 4.7 5.0

Erythrocytes (T/l)

1

2

3

4

MQ 2015/1 Page 7/181

Page 8: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Erythrocytes

H1 Hematology

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Abx Micros 918 97.6 0.7 1.7 3.3 5.1 e

2 Microsemi 204 98.5 1.5 0.0 3.3 4.7 e

3 Sysmex KX21 446 98.0 0.4 1.6 3.4 3.3 e

4 Sysmex PocH - 100i 219 97.7 0.5 1.8 3.5 3.4 e

5 Sysmex XP 300 147 98.6 0.7 0.7 3.4 2.8 e

6 Mythic 244 98.0 0.8 1.2 3.3 4.4 e

7 Swelab 68 98.5 1.5 0.0 3.4 4.8 e

8 MS4 8 100.0 0.0 0.0 3.4 5.0 e

9 Abacus Junior 12 100.0 0.0 0.0 3.6 4.3 e

10 Medonic 19 100.0 0.0 0.0 3.4 3.5 e

11 Samsung HC10 42 100.0 0.0 0.0 3.4 4.3 e

12 Nihon Kohden Celltac 34 97.1 2.9 0.0 3.5 7.1 e

1.5 1.9 2.3 2.7 3.1 3.5 3.9 4.3 4.7 5.1 5.5

Erythrocytes (T/l)

1

2

3

4

5

6

7

8

9

10

11

12

MQ 2015/1 Page 8/181

Page 9: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Leucocytes

H1 Hematology

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Automat 42 95.2 2.4 2.4 5.96 8.9 e

2 Microscopic 62 87.1 4.8 8.1 5.29 14.7 e

3 Sysmex XT/XE/XS 39 100.0 0.0 0.0 6.00 3.0 e

4 ABX Pentra 11 100.0 0.0 0.0 5.78 7.0 e

3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0

Leucocytes (G/l)

1

2

3

4

MQ 2015/1 Page 9/181

Page 10: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Leucocytes

H1 Hematology

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Abx Micros 918 98.9 0.7 0.4 5.46 5.5 e

2 Microsemi 204 99.5 0.5 0.0 5.59 4.3 e

3 Sysmex KX21 446 99.3 0.0 0.7 5.64 3.4 e

4 Sysmex PocH - 100i 219 98.2 0.0 1.8 5.69 4.1 e

5 Sysmex XP 300 148 99.3 0.0 0.7 5.87 3.6 e

6 Mythic 241 99.2 0.0 0.8 5.59 6.3 e

7 Nihon Kohden Celltac 34 100.0 0.0 0.0 5.82 4.5 e

8 Swelab 68 98.5 1.5 0.0 6.07 6.3 e

9 MS4 8 100.0 0.0 0.0 6.01 11.3 e*

10 Abacus Junior 12 100.0 0.0 0.0 7.03 7.6 e

11 Medonic 19 100.0 0.0 0.0 6.05 5.9 e

12 Samsung HC10 42 97.6 0.0 2.4 5.58 3.0 e

3.0 3.7 4.4 5.1 5.8 6.5 7.2 7.9 8.6 9.3 10.0

Leucocytes (G/l)

1

2

3

4

5

6

7

8

9

10

11

12

MQ 2015/1 Page 10/181

Page 11: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Thrombocytes

H1 Hematology

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Automat 39 100.0 0.0 0.0 233.4 10.4 e

2 Microscopic 37 86.5 13.5 0.0 216.0 14.1 e

3 Sysmex XT/XE/XS 39 100.0 0.0 0.0 228.2 2.6 e

4 Advia 120 4 100.0 0.0 0.0 219.5 4.4 e

5 ABX Pentra 11 100.0 0.0 0.0 251.5 5.9 e

140 160 180 200 220 240 260 280 300 320 340

Thrombocytes (G/l)

1

2

3

4

5

MQ 2015/1 Page 11/181

Page 12: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Thrombocytes

H1 Hematology

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Abx Micros 916 96.5 2.2 1.3 236.8 9.1 e

2 Microsemi 204 98.5 0.5 1.0 246.8 5.7 e

3 Sysmex KX21 446 98.9 0.0 1.1 234.1 4.0 e

4 Sysmex PocH - 100i 218 98.2 0.0 1.8 238.7 4.9 e

5 Sysmex XP 300 148 99.3 0.0 0.7 242.1 4.0 e

6 Mythic 244 95.9 2.9 1.2 217.9 11.0 e

7 Swelab 68 98.5 1.5 0.0 220.1 9.8 e

8 MS4 8 75.0 25.0 0.0 194.0 21.1 e*

9 Abacus Junior 12 100.0 0.0 0.0 267.7 7.1 e

10 Medonic 19 100.0 0.0 0.0 226.7 5.3 e

11 Nihon Kohden Celltac 34 97.1 2.9 0.0 243.9 9.0 e

12 Samsung HC10 42 100.0 0.0 0.0 231.1 8.2 e

100 125 150 175 200 225 250 275 300 325 350

Thrombocytes (G/l)

1

2

3

4

5

6

7

8

9

10

11

12

MQ 2015/1 Page 12/181

Page 13: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

CRP

I1 CRP

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Afinion 1144 99.4 0.5 0.1 44.7 7.8 e

2 NycoCard SingleTest- 494 80.4 7.7 11.9 49.4 11.7 e

3 Abx Micros 152 93.5 3.9 2.6 45.1 9.3 e

4 ABX Micros CRP200 341 95.3 3.8 0.9 44.0 9.9 e

5 Quick Read go 73 98.6 0.0 1.4 48.0 7.2 e

6 Turbidimetry 40 100.0 0.0 0.0 44.5 7.1 e

7 Cobas 11 100.0 0.0 0.0 44.5 5.9 e

8 Fuji Dri-Chem 22 91.0 4.5 4.5 47.3 12.6 e*

9 Eurolyser 117 70.9 7.7 21.4 40.8 12.6 e

10 AQT 90 FLEX 6 100.0 0.0 0.0 50.5 9.9 e*

11 Spotchem D-Concept 7 100.0 0.0 0.0 46.9 2.9 e

12 Other methods 4 100.0 0.0 0.0 42.8 5.9 e*

20 25 30 35 40 45 50 55 60 65 70

CRP (mg/l)

1

2

3

4

5

6

7

8

9

10

11

12

MQ 2015/1 Page 13/181

Page 14: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

CRP

I1 CRP

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 QuikRead (Vollblut) 192 94.8 2.1 3.1 76.0 6.5 e

50 55 60 65 70 75 80 85 90 95 100

CRP (mg/l)

1

MQ 2015/1 Page 14/181

Page 15: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

CRP emi

I6 CRP emi

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Microsemi 200 96.5 3.0 0.5 45.0 9.1 e

30 33 36 39 42 45 48 51 54 57 60

CRP emi (mg/l)

1

MQ 2015/1 Page 15/181

Page 16: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

IgG

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Turbidimetry 10 100.0 0.0 0.0 10.3 4.8 e

2 Nephelometry 7 100.0 0.0 0.0 10.8 6.4 e

7.0 7.7 8.4 9.1 9.8 10.5 11.2 11.9 12.6 13.3 14.0

IgG (g/l)

1

2

MQ 2015/1 Page 16/181

Page 17: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

IgA

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Turbidimetry 11 100.0 0.0 0.0 1.9 3.4 e

2 Nephelometry 7 100.0 0.0 0.0 2.1 5.9 e

1.30 1.45 1.60 1.75 1.90 2.05 2.20 2.35 2.50 2.65 2.80

IgA (g/l)

1

2

MQ 2015/1 Page 17/181

Page 18: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

IgM

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Turbidimetry 4 100.0 0.0 0.0 1.0 2.2 e

2 Nephelometry 7 100.0 0.0 0.0 1.1 7.4 e

3 Cobas Integra 800/40 6 100.0 0.0 0.0 1.0 2.4 e

0.70 0.77 0.84 0.91 0.98 1.05 1.12 1.19 1.26 1.33 1.40

IgM (g/l)

1

2

3

MQ 2015/1 Page 18/181

Page 19: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

IgE

I2 Plasmaproteins

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 9 88.9 0.0 11.1 99 8.7 e*

70 76 82 88 94 100 106 112 118 124 130

IgE (kU/L)

1

MQ 2015/1 Page 19/181

Page 20: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Alpha-1-Antitrypsin

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Nephelometry 4 100.0 0.0 0.0 1.12 11.3 e*

0.80 0.87 0.94 1.01 1.08 1.15 1.22 1.29 1.36 1.43 1.50

Alpha-1-Antitrypsin (g/l)

1

MQ 2015/1 Page 20/181

Page 21: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Anti-Streptolysin-Antibodies

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 10 100.0 0.0 0.0 114 8.1 e

80 87 94 101 108 115 122 129 136 143 150

Anti-Streptolysin-Antibodies (kIU/l)

1

MQ 2015/1 Page 21/181

Page 22: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Complement C3

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 12 100.0 0.0 0.0 1.33 8.4 e

0.90 0.99 1.08 1.17 1.26 1.35 1.44 1.53 1.62 1.71 1.80

Complement C3 (g/l)

1

MQ 2015/1 Page 22/181

Page 23: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Complement C4

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 11 100.0 0.0 0.0 0.26 6.9 e

0.180 0.196 0.212 0.228 0.244 0.260 0.276 0.292 0.308 0.324 0.340

Complement C4 (g/l)

1

MQ 2015/1 Page 23/181

Page 24: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Haptoglobin

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 13 100.0 0.0 0.0 1.13 4.5 e

0.80 0.87 0.94 1.01 1.08 1.15 1.22 1.29 1.36 1.43 1.50

Haptoglobin (g/l)

1

MQ 2015/1 Page 24/181

Page 25: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Transferrin

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 14 100.0 0.0 0.0 2.12 3.2 e

1.50 1.62 1.74 1.86 1.98 2.10 2.22 2.34 2.46 2.58 2.70

Transferrin (g/l)

1

MQ 2015/1 Page 25/181

Page 26: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Präalbumin

I2 Plasmaproteins

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 8 100.0 0.0 0.0 177.0 3.8 e

120 131 142 153 164 175 186 197 208 219 230

Präalbumin (mg/l)

1

MQ 2015/1 Page 26/181

Page 27: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Albumine

K1 Clinical Chemistry

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 14 100.0 0.0 0.0 34 5.9 e*

2 Cobas 14 100.0 0.0 0.0 36 3.0 e

3 Fuji Dri-Chem 165 98.8 0.0 1.2 42 3.7 e

4 Spotchem/Ready 45 93.4 2.2 4.4 35 4.8 e

5 Spotchem D-Concept 64 95.3 1.6 3.1 44 5.7 e

6 Piccolo 27 100.0 0.0 0.0 38 2.5 e

7 Abx Mira 8 100.0 0.0 0.0 34 5.1 e*

8 Hitachi S40/M40 8 100.0 0.0 0.0 35 3.3 e

25 28 31 34 37 40 43 46 49 52 55

Albumine (g/l)

1

2

3

4

5

6

7

8

MQ 2015/1 Page 27/181

Page 28: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Alkaline phosphatase

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 IFCC/SGKC 37'C 9 88.9 11.1 0.0 172 7.3 e*

2 Cobas 19 100.0 0.0 0.0 161 5.4 e

3 Reflotron 707 97.4 0.8 1.8 179 6.0 e

4 Fuji Dri-Chem 640 98.3 0.3 1.4 169 4.7 e

5 Spotchem/Ready 127 92.9 5.5 1.6 188 8.4 e

6 Spotchem D-Concept 118 98.4 0.8 0.8 169 6.4 e

7 Hitachi S40/M40 12 100.0 0.0 0.0 137 5.2 e

8 Olympus 5 100.0 0.0 0.0 207 2.4 e

9 Piccolo 26 100.0 0.0 0.0 179 3.8 e

10 Abx Mira 21 95.2 0.0 4.8 171 6.2 e

100 116 132 148 164 180 196 212 228 244 260

Alkaline phosphatase (U/l)

1

2

3

4

5

6

7

8

9

10

MQ 2015/1 Page 28/181

Page 29: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Amylase

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 IFCC EPS liquid 37°C 10 100.0 0.0 0.0 162 5.9 e

2 Cobas 7 100.0 0.0 0.0 155 1.0 e

3 Reflotron 191 98.0 1.0 1.0 177 5.6 e

4 Fuji Dri-Chem 476 99.0 0.2 0.8 146 3.7 e

5 Spotchem/Ready 83 90.4 7.2 2.4 182 9.0 e

6 Spotchem D-Concept 88 100.0 0.0 0.0 188 5.6 e

7 Piccolo 25 100.0 0.0 0.0 138 2.2 e

8 Abx Mira 9 100.0 0.0 0.0 140 5.0 e

9 Hitachi S40/M40 7 100.0 0.0 0.0 175 5.4 e

100 115 130 145 160 175 190 205 220 235 250

Amylase (U/l)

1

2

3

4

5

6

7

8

9

MQ 2015/1 Page 29/181

Page 30: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Pancreatic amylase

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 IFCC EPS liquid 37°C 18 94.4 0.0 5.6 128 6.0 e

2 Cobas 13 100.0 0.0 0.0 128 5.1 e

3 Reflotron 462 98.0 0.9 1.1 149 5.9 e

100 110 120 130 140 150 160 170 180 190 200

Pancreatic amylase (U/l)

1

2

3

MQ 2015/1 Page 30/181

Page 31: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Bilirubin

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 12 100.0 0.0 0.0 60.7 4.7 e

2 Cobas 18 100.0 0.0 0.0 56.9 4.6 e

3 Reflotron 521 96.8 1.3 1.9 53.8 6.0 e

4 Fuji Dri-Chem 481 98.4 0.4 1.2 57.3 4.3 e

5 Spotchem/Ready 100 95.0 2.0 3.0 60.1 6.0 e

6 Spotchem D-Concept 95 96.8 0.0 3.2 47.0 4.0 e

7 Beckman/Olympus 5 100.0 0.0 0.0 65.2 2.7 e

8 Piccolo 24 95.8 4.2 0.0 59.9 6.4 e

9 Abx Mira 20 95.0 0.0 5.0 61.5 6.5 e

10 Hitachi S40/M40 11 100.0 0.0 0.0 65.9 4.1 e

30 35 40 45 50 55 60 65 70 75 80

Bilirubin (µmol/l)

1

2

3

4

5

6

7

8

9

10

MQ 2015/1 Page 31/181

Page 32: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Bilirubin direct

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Fuji Dri-Chem 30 96.7 0.0 3.3 33.2 5.3 e

25.0 26.5 28.0 29.5 31.0 32.5 34.0 35.5 37.0 38.5 40.0

Bilirubin direct (µmol/l)

1

MQ 2015/1 Page 32/181

Page 33: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Calcium

K1 Clinical Chemistry

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 17 100.0 0.0 0.0 2.51 2.2 e

2 Cobas 13 100.0 0.0 0.0 2.56 2.0 e

3 Fuji Dri-Chem 341 98.2 0.0 1.8 2.63 4.1 e

4 Spotchem/Ready 49 96.0 2.0 2.0 2.41 5.2 e

5 Spotchem D-Concept 62 88.7 9.7 1.6 2.07 7.1 e

6 Piccolo 25 100.0 0.0 0.0 2.51 1.6 e

7 Abx Mira 14 100.0 0.0 0.0 2.49 3.0 e

8 Hitachi S40/M40 9 100.0 0.0 0.0 2.48 5.3 e*

1.50 1.66 1.82 1.98 2.14 2.30 2.46 2.62 2.78 2.94 3.10

Calcium (mmol/l)

1

2

3

4

5

6

7

8

MQ 2015/1 Page 33/181

Page 34: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Chloride

K1 Clinical Chemistry

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ISE 14 92.9 7.1 0.0 99 2.9 e*

2 Cobas 11 100.0 0.0 0.0 96 2.6 e*

3 Fuji Dri-Chem 560 95.9 2.1 2.0 104 2.4 e

4 Spotchem D-Concept 107 92.5 1.9 5.6 107 2.4 e

5 Spotchem EL-SE 1520 116 93.2 3.4 3.4 111 3.1 e

6 Piccolo 16 93.7 0.0 6.3 97 2.8 e

7 iStat Chem8 4 100.0 0.0 0.0 103 1.3 e

85 89 93 97 101 105 109 113 117 121 125

Chloride (mmol/l)

1

2

3

4

5

6

7

MQ 2015/1 Page 34/181

Page 35: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Cholesterol total

K1 Clinical Chemistry

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 18 100.0 0.0 0.0 4.9 3.8 e

2 Cobas 17 100.0 0.0 0.0 4.8 3.8 e

3 Reflotron 831 97.2 2.0 0.8 4.6 4.1 e

4 Fuji Dri-Chem 662 99.0 0.5 0.5 4.8 3.3 e

5 Spotchem/Ready 151 92.8 4.6 2.6 4.8 4.7 e

6 Spotchem D-Concept 122 95.9 3.3 0.8 4.7 4.1 e

7 Piccolo 22 100.0 0.0 0.0 4.9 1.5 e

8 Cholestech LDX 191 95.9 3.1 1.0 4.7 4.5 e

9 Abx Mira 21 95.2 4.8 0.0 4.8 3.7 e

10 Hitachi S40/M40 12 100.0 0.0 0.0 4.8 2.3 e

3.90 4.07 4.24 4.41 4.58 4.75 4.92 5.09 5.26 5.43 5.60

Cholesterol total (mmol/l)

1

2

3

4

5

6

7

8

9

10

MQ 2015/1 Page 35/181

Page 36: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Cholesterin HDL

K1 Clinical Chemistry

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Wet chemistry, direc 16 93.7 0.0 6.3 1.28 5.5 e

2 Cobas 15 100.0 0.0 0.0 1.05 5.3 e

3 Reflotron 626 93.4 3.7 2.9 1.13 9.7 e

4 Fuji Dri-Chem 622 99.1 0.3 0.6 1.32 3.7 e

5 Spotchem/Ready 137 94.1 1.5 4.4 0.94 8.0 e

6 Spotchem D-Concept 121 93.4 4.1 2.5 1.01 10.1 e

7 Piccolo 22 100.0 0.0 0.0 1.19 7.0 e

8 Cholestech LDX 191 95.3 2.1 2.6 1.29 7.8 e

9 Abx Mira 20 100.0 0.0 0.0 1.28 5.4 e

10 Hitachi S40/M40 11 81.8 9.1 9.1 1.32 8.7 e*

0.50 0.63 0.76 0.89 1.02 1.15 1.28 1.41 1.54 1.67 1.80

Cholesterin HDL (mmol/l)

1

2

3

4

5

6

7

8

9

10

MQ 2015/1 Page 36/181

Page 37: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Creatine kinase

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 IFCC/SGKC 37'C 17 100.0 0.0 0.0 311 5.0 e

2 Cobas 16 100.0 0.0 0.0 325 4.1 e

3 Reflotron 430 94.1 4.0 1.9 293 8.7 e

4 Fuji Dri-Chem 410 99.5 0.5 0.0 327 4.0 e

5 Spotchem/Ready 59 84.7 6.8 8.5 275 9.8 e

6 Spotchem D-Concept 74 97.2 1.4 1.4 316 6.3 e

7 Piccolo 7 100.0 0.0 0.0 335 2.9 e

8 Abx Mira 17 94.1 5.9 0.0 307 5.6 e

9 Hitachi S40/M40 6 100.0 0.0 0.0 272 5.1 e

200 221 242 263 284 305 326 347 368 389 410

Creatine kinase (U/l)

1

2

3

4

5

6

7

8

9

MQ 2015/1 Page 37/181

Page 38: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Iron

K1 Clinical Chemistry

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 8 100.0 0.0 0.0 28 6.1 e

2 Cobas 11 100.0 0.0 0.0 28 2.3 e

3 Abx Mira 6 100.0 0.0 0.0 27 4.0 e

20.0 21.5 23.0 24.5 26.0 27.5 29.0 30.5 32.0 33.5 35.0

Iron (µmol/l)

1

2

3

MQ 2015/1 Page 38/181

Page 39: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Gamma-glutamyltransferase

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 IFCC/SGKC 37'C 6 100.0 0.0 0.0 81 4.1 e

2 Cobas 17 100.0 0.0 0.0 82 6.4 e

3 Reflotron 919 98.5 1.2 0.3 109 6.1 e

4 Fuji Dri-Chem 695 99.3 0.3 0.4 110 4.6 e

5 Spotchem/Ready 155 96.8 1.9 1.3 95 7.7 e

6 Spotchem D-Concept 134 97.8 1.5 0.7 100 7.0 e

7 DGKC 37'C 10 100.0 0.0 0.0 84 7.1 e*

8 Piccolo 28 100.0 0.0 0.0 76 4.1 e

9 Abx Mira 22 95.5 4.5 0.0 83 5.3 e

10 Hitachi S40/M40 14 92.9 0.0 7.1 93 2.7 e

50 60 70 80 90 100 110 120 130 140 150

Gamma-glutamyltransferase (U/l)

1

2

3

4

5

6

7

8

9

10

MQ 2015/1 Page 39/181

Page 40: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Glucose

K1 Clinical Chemistry

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 25 92.0 4.0 4.0 9.5 4.9 e

2 Cobas 18 100.0 0.0 0.0 9.8 2.9 e

3 Reflotron 941 93.7 3.6 2.7 9.5 4.8 e

4 Fuji Dri-Chem 656 99.2 0.6 0.2 9.0 2.1 e

5 Spotchem/Ready 141 92.2 3.5 4.3 9.8 4.4 e

6 Spotchem D-Concept 125 99.2 0.0 0.8 9.4 4.2 e

7 Piccolo 31 100.0 0.0 0.0 9.6 2.0 e

8 Cholestech LDX 155 84.5 10.3 5.2 9.0 5.9 e

9 Abx Mira 22 100.0 0.0 0.0 9.6 4.0 e

10 Lange 5 100.0 0.0 0.0 8.8 3.1 e*

11 Hitachi S40/M40 15 86.7 13.3 0.0 9.7 5.3 e*

12 iStat Chem8 4 100.0 0.0 0.0 9.0 1.3 e

7.0 7.4 7.8 8.2 8.6 9.0 9.4 9.8 10.2 10.6 11.0

Glucose (mmol/l)

1

2

3

4

5

6

7

8

9

10

11

12

MQ 2015/1 Page 40/181

Page 41: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Glucose

K1 Clinical Chemistry

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Accu-Chek Aviva 380 98.9 0.3 0.8 10.1 3.1 e

2 Accu-Chek Inform 2 229 97.8 1.3 0.9 10.1 3.5 e

3 Accu-Chek Mobile 5 100.0 0.0 0.0 11.1 5.9 e*

4 Bayer Contour 2 (5s) 66 92.5 3.0 4.5 7.7 4.4 e

5 Bayer Contour XT/NEX 1103 95.6 3.0 1.4 10.2 4.3 e

6 Bayer Breeze 2 19 94.7 5.3 0.0 16.2 5.5 e*

7 Glucocard 10 90.0 0.0 10.0 14.7 4.3 e*

8 Omnitest 11 90.9 9.1 0.0 17.3 5.1 e*

9 Hemocue 201+ P-equiv 79 97.4 1.3 1.3 10.9 4.0 e

10 Hemocue 201RT P-equi 33 90.9 3.0 6.1 10.8 2.8 e

11 Freestyle precision/ 4 75.0 25.0 0.0 10.4 6.0 e*

12 Freestyle Freedom li 11 100.0 0.0 0.0 10.6 5.0 e*

6.0 7.5 9.0 10.5 12.0 13.5 15.0 16.5 18.0 19.5 21.0

Glucose (mmol/l)

1

2

3

4

5

6

7

8

9

10

11

12

MQ 2015/1 Page 41/181

Page 42: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Glucose B

K1 Clinical Chemistry

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Bayer Elite 10 80.0 10.0 10.0 10.9 6.2 e*

2 Hemocue 201+ (alt) 59 98.3 1.7 0.0 10.4 4.7 e

3 mylife Pura 53 100.0 0.0 0.0 11.5 2.4 e

4 AccuChek Sensor 7 100.0 0.0 0.0 10.2 3.4 e*

5 OneTouch Ultra 25 76.0 0.0 24.0 13.5 4.0 e

6 OneTouch Verio 4 100.0 0.0 0.0 9.7 1.9 e

7 AccuChek Compact 6 100.0 0.0 0.0 10.5 3.0 e*

8 Bayer Contour (15s) 89 88.8 5.6 5.6 12.5 5.0 e

9 Healthpro 15 100.0 0.0 0.0 16.3 4.3 e

10 Sanofi BG Star 7 100.0 0.0 0.0 13.5 2.2 e

11 Mylife UNIO 4 75.0 0.0 25.0 10.7 0.5 e

8.0 9.1 10.2 11.3 12.4 13.5 14.6 15.7 16.8 17.9 19.0

Glucose B (mmol/l)

1

2

3

4

5

6

7

8

9

10

11

MQ 2015/1 Page 42/181

Page 43: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Uric Acid

K1 Clinical Chemistry

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 18 94.4 0.0 5.6 382 4.1 e

2 Cobas 14 100.0 0.0 0.0 375 2.5 e

3 Reflotron 817 97.2 1.2 1.6 402 4.2 e

4 Fuji Dri-Chem 655 99.5 0.0 0.5 408 2.1 e

5 Spotchem/Ready 129 94.6 2.3 3.1 354 4.8 e

6 Spotchem D-Concept 119 100.0 0.0 0.0 376 4.0 e

7 Piccolo 23 95.7 4.3 0.0 319 6.1 e

8 Abx Mira 20 100.0 0.0 0.0 364 3.6 e

9 Hitachi S40/M40 13 92.3 0.0 7.7 378 3.2 e

250 275 300 325 350 375 400 425 450 475 500

Uric Acid (µmol/l)

1

2

3

4

5

6

7

8

9

MQ 2015/1 Page 43/181

Page 44: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Urea

K1 Clinical Chemistry

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 16 100.0 0.0 0.0 15.3 4.2 e

2 Cobas 17 100.0 0.0 0.0 14.9 4.0 e

3 Reflotron 357 96.6 1.7 1.7 15.7 6.3 e

4 Fuji Dri-Chem 411 99.0 0.0 1.0 15.4 2.2 e

5 Spotchem/Ready 89 79.8 10.1 10.1 13.4 8.8 e

6 Spotchem D-Concept 77 80.5 10.4 9.1 14.5 9.3 e

7 Piccolo 29 100.0 0.0 0.0 14.8 2.8 e

8 Abx Mira 11 100.0 0.0 0.0 14.9 4.4 e

9 Hitachi S40/M40 9 88.9 0.0 11.1 14.5 2.7 e

10 iStat Chem8 6 83.3 0.0 16.7 18.6 2.9 e

9.0 10.5 12.0 13.5 15.0 16.5 18.0 19.5 21.0 22.5 24.0

Urea (mmol/l)

1

2

3

4

5

6

7

8

9

10

MQ 2015/1 Page 44/181

Page 45: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Potassium

K1 Clinical Chemistry

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ISE 26 96.2 0.0 3.8 4.60 1.8 e

2 Cobas 18 100.0 0.0 0.0 4.67 1.9 e

3 Reflotron 850 92.7 5.3 2.0 4.87 3.1 e

4 Fuji Dri-Chem 689 95.2 3.2 1.6 4.59 2.2 e

5 Spotchem D-Concept 120 97.5 0.8 1.7 4.40 1.9 e

6 Spotchem EL-SE 1520 121 92.5 5.8 1.7 4.34 2.9 e

7 Piccolo 17 70.6 17.6 11.8 4.76 4.5 e*

8 Abx Mira 7 71.4 14.3 14.3 4.53 3.3 e*

9 iStat Chem8 5 100.0 0.0 0.0 4.50 1.2 e

3.90 4.05 4.20 4.35 4.50 4.65 4.80 4.95 5.10 5.25 5.40

Potassium (mmol/l)

1

2

3

4

5

6

7

8

9

MQ 2015/1 Page 45/181

Page 46: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Creatinine

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 7 100.0 0.0 0.0 259 1.5 e

2 Cobas 19 100.0 0.0 0.0 246 4.5 e

3 Reflotron 1025 98.2 0.7 1.1 297 5.8 e

4 Fuji Dri-Chem 725 98.5 0.7 0.8 251 4.9 e

5 Jaffé 8 100.0 0.0 0.0 256 5.0 e

6 Enzymatic 4 100.0 0.0 0.0 258 1.6 e

7 Piccolo 29 100.0 0.0 0.0 250 5.0 e

8 Abx Mira 22 100.0 0.0 0.0 253 5.9 e

9 Hitachi S40/M40 14 92.9 0.0 7.1 253 2.8 e

150 175 200 225 250 275 300 325 350 375 400

Creatinine (µmol/l)

1

2

3

4

5

6

7

8

9

MQ 2015/1 Page 46/181

Page 47: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Creatinine E

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Statsensor i / Nova 26 92.3 7.7 0.0 462 11.7 e*

2 iStat Chem8 7 100.0 0.0 0.0 279 1.3 e

3 ABL700/800 Radiomete 10 100.0 0.0 0.0 272 3.2 e

200 240 280 320 360 400 440 480 520 560 600

Creatinine E (µmol/l)

1

2

3

MQ 2015/1 Page 47/181

Page 48: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

eGFR

K1 Clinical Chemistry

QUALAB tolerance : 30 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 CKD-EPI 739 95.6 1.4 3.0 29 12.7 a

2 Cockcroft-Gault 46 89.2 6.5 4.3 33 16.7 a

3 MDRD 19 79.0 10.5 10.5 28 21.0 a

10 14 18 22 26 30 34 38 42 46 50

eGFR ()

1

2

3

MQ 2015/1 Page 48/181

Page 49: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

LDH

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 IFCC 18 100.0 0.0 0.0 222 5.2 e

2 Cobas 9 100.0 0.0 0.0 450 1.1 e

3 Fuji Dri-Chem 143 97.2 0.7 2.1 193 5.1 e

4 Spotchem/Ready 36 91.7 0.0 8.3 170 7.0 e

5 Spotchem D-Concept 35 94.3 5.7 0.0 172 10.5 e

6 Abx Mira 12 100.0 0.0 0.0 221 7.4 e

100 150 200 250 300 350 400 450 500 550 600

LDH (U/l)

1

2

3

4

5

6

MQ 2015/1 Page 49/181

Page 50: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Magnesium

K1 Clinical Chemistry

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 13 92.3 0.0 7.7 1.08 4.1 e

2 Cobas 12 100.0 0.0 0.0 1.10 2.8 e

3 Fuji Dri-Chem 111 98.2 0.0 1.8 1.14 4.3 e

4 Spotchem D-Concept 22 100.0 0.0 0.0 0.90 5.5 e

5 Spotchem/Ready 16 100.0 0.0 0.0 0.92 4.1 e

6 Piccolo 4 100.0 0.0 0.0 1.08 2.7 e

0.70 0.77 0.84 0.91 0.98 1.05 1.12 1.19 1.26 1.33 1.40

Magnesium (mmol/l)

1

2

3

4

5

6

MQ 2015/1 Page 50/181

Page 51: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Sodium

K1 Clinical Chemistry

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ISE 25 92.0 0.0 8.0 144 1.8 e

2 Cobas 17 100.0 0.0 0.0 143 1.4 e

3 Fuji Dri-Chem 640 97.2 1.7 1.1 145 1.8 e

4 Spotchem D-Concept 116 98.3 1.7 0.0 139 1.7 e

5 Spotchem EL-SE 1520 121 97.5 0.8 1.7 139 2.1 e

6 Piccolo 18 100.0 0.0 0.0 140 1.7 e

7 Abx Mira 8 100.0 0.0 0.0 146 2.4 e*

8 iStat Chem8 5 100.0 0.0 0.0 143 0.3 e

125.0 128.5 132.0 135.5 139.0 142.5 146.0 149.5 153.0 156.5 160.0

Sodium (mmol/l)

1

2

3

4

5

6

7

8

MQ 2015/1 Page 51/181

Page 52: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Phosphate

K1 Clinical Chemistry

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 11 100.0 0.0 0.0 1.5 3.3 e

2 Cobas 12 100.0 0.0 0.0 1.5 4.3 e

3 Fuji Dri-Chem 72 98.6 1.4 0.0 1.6 3.5 e

4 Spotchem D-Concept 15 100.0 0.0 0.0 1.7 5.1 e

5 Spotchem/Ready 6 100.0 0.0 0.0 1.4 2.8 e

6 Piccolo 7 100.0 0.0 0.0 1.8 2.7 e

7 Abx Mira 5 100.0 0.0 0.0 1.6 3.7 e

1.00 1.12 1.24 1.36 1.48 1.60 1.72 1.84 1.96 2.08 2.20

Phosphate (mmol/l)

1

2

3

4

5

6

7

MQ 2015/1 Page 52/181

Page 53: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Protein total

K1 Clinical Chemistry

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 15 100.0 0.0 0.0 56.0 3.3 e

2 Cobas 13 100.0 0.0 0.0 54.7 2.1 e

3 Fuji Dri-Chem 175 98.9 0.0 1.1 52.9 2.6 e

4 Spotchem/Ready 40 90.0 10.0 0.0 55.8 7.5 e

5 Spotchem D-Concept 57 82.4 8.8 8.8 58.3 6.6 e

6 Piccolo 22 100.0 0.0 0.0 57.3 1.7 e

7 Abx Mira 8 100.0 0.0 0.0 58.3 3.4 e

8 Hitachi S40/M40 5 100.0 0.0 0.0 58.0 4.2 e*

45.0 47.5 50.0 52.5 55.0 57.5 60.0 62.5 65.0 67.5 70.0

Protein total (g/l)

1

2

3

4

5

6

7

8

MQ 2015/1 Page 53/181

Page 54: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Aspartate aminotransferase

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 IFCC with Pyridox 37 14 100.0 0.0 0.0 134 3.6 e

2 Cobas 18 94.4 0.0 5.6 129 3.6 e

3 Reflotron 933 97.2 1.4 1.4 167 6.6 e

4 Fuji Dri-Chem 693 99.7 0.0 0.3 127 2.8 e

5 Spotchem/Ready 163 97.0 1.8 1.2 117 5.8 e

6 Spotchem D-Concept 128 100.0 0.0 0.0 130 5.4 e

7 IFCC with Pyridox 37 5 100.0 0.0 0.0 134 1.5 e

8 Piccolo 29 100.0 0.0 0.0 126 2.9 e

9 Abx Mira 22 100.0 0.0 0.0 131 5.7 e

10 Hitachi S40/M40 16 87.5 0.0 12.5 134 2.2 e

90 105 120 135 150 165 180 195 210 225 240

Aspartate aminotransferase (U/l)

1

2

3

4

5

6

7

8

9

10

MQ 2015/1 Page 54/181

Page 55: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Alanine aminotransferase

K1 Clinical Chemistry

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 IFCC with Pyridox 37 15 100.0 0.0 0.0 98 4.0 e

2 Cobas 19 94.7 0.0 5.3 93 3.1 e

3 Reflotron 964 98.1 1.0 0.9 90 5.0 e

4 Fuji Dri-Chem 711 98.7 0.7 0.6 92 4.1 e

5 Spotchem/Ready 165 96.4 1.2 2.4 76 5.8 e

6 Spotchem D-Concept 133 98.4 0.8 0.8 68 6.1 e

7 Piccolo 30 96.7 0.0 3.3 85 3.1 e

8 Abx Mira 22 95.5 4.5 0.0 94 7.0 e

9 Hitachi S40/M40 15 86.7 0.0 13.3 97 3.5 e

40 48 56 64 72 80 88 96 104 112 120

Alanine aminotransferase (U/l)

1

2

3

4

5

6

7

8

9

MQ 2015/1 Page 55/181

Page 56: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Triglycerides

K1 Clinical Chemistry

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 20 100.0 0.0 0.0 1.73 6.3 e

2 Cobas 18 100.0 0.0 0.0 1.66 4.8 e

3 Reflotron 725 95.6 2.5 1.9 1.74 7.9 e

4 Fuji Dri-Chem 643 99.0 0.2 0.8 1.73 3.3 e

5 Spotchem/Ready 144 99.3 0.0 0.7 1.54 4.8 e

6 Spotchem D-Concept 121 98.3 0.0 1.7 1.71 4.6 e

7 Hitachi S40/M40 11 81.8 0.0 18.2 1.64 3.7 e

8 Piccolo 20 100.0 0.0 0.0 1.88 3.0 e

9 Cholestech LDX 191 99.0 0.0 1.0 1.73 5.5 e

10 Abx Mira 20 100.0 0.0 0.0 1.66 3.6 e

1.00 1.15 1.30 1.45 1.60 1.75 1.90 2.05 2.20 2.35 2.50

Triglycerides (mmol/l)

1

2

3

4

5

6

7

8

9

10

MQ 2015/1 Page 56/181

Page 57: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Fructosamine

K1 Clinical Chemistry

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Spotchem/Ready 4 100.0 0.0 0.0 237 7.5 e*

190 199 208 217 226 235 244 253 262 271 280

Fructosamine (µmol/l)

1

MQ 2015/1 Page 57/181

Page 58: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Bicarbonat

K1 Clinical Chemistry

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Piccolo 6 100.0 0.0 0.0 22 4.7 e*

18.0 18.8 19.6 20.4 21.2 22.0 22.8 23.6 24.4 25.2 26.0

Bicarbonat (mmol/l)

1

MQ 2015/1 Page 58/181

Page 59: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

LDL Cholesterin

K1 Clinical Chemistry

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Abx Mira 10 100.0 0.0 0.0 2.7 6.0 e

2 Standard chemistry 7 100.0 0.0 0.0 2.9 10.1 e*

3 Roche, Cobas 5 100.0 0.0 0.0 3.0 1.4 e

4 Hitachi S40/M40 5 80.0 0.0 20.0 2.5 3.9 e

1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00

LDL Cholesterin (mmol/l)

1

2

3

4

MQ 2015/1 Page 59/181

Page 60: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Lithium

K1 Clinical Chemistry

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 14 100.0 0.0 0.0 1.17 5.3 e

0.90 0.95 1.00 1.05 1.10 1.15 1.20 1.25 1.30 1.35 1.40

Lithium (mmol/l)

1

MQ 2015/1 Page 60/181

Page 61: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Lactate

K1 Clinical Chemistry

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 7 100.0 0.0 0.0 3.67 4.6 e

3.00 3.15 3.30 3.45 3.60 3.75 3.90 4.05 4.20 4.35 4.50

Lactate (mmol/l)

1

MQ 2015/1 Page 61/181

Page 62: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Lipase

K34 Lipase

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Abx Mira 6 83.3 16.7 0.0 41.5 11.2 e*

2 Architect 4 100.0 0.0 0.0 46.0 2.5 e

3 Beckman/Olympus 4 100.0 0.0 0.0 47.0 4.8 e*

4 Standard chemistry 8 100.0 0.0 0.0 44.3 4.8 e

5 Fuji Dri-Chem 47 95.7 0.0 4.3 57.4 3.7 e

30 34 38 42 46 50 54 58 62 66 70

Lipase (U/l)

1

2

3

4

5

MQ 2015/1 Page 62/181

Page 63: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Creatinine SP

K13 Creatinine Spotchem

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Spotchem/Ready 159 84.9 10.7 4.4 92 11.3 e

2 Spotchem D-Concept 130 93.1 4.6 2.3 81 8.3 e

60 66 72 78 84 90 96 102 108 114 120

Creatinine SP (µmol/l)

1

2

MQ 2015/1 Page 63/181

Page 64: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

eGFR (Spotchem)

K13 Creatinine Spotchem

QUALAB tolerance : 30 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 CKD-EPI 91 91.2 0.0 8.8 119 11.0 a

2 Cockcroft-Gault 6 83.3 0.0 16.7 129 15.5 a

3 MDRD 4 75.0 0.0 25.0 108 16.6 a

70 81 92 103 114 125 136 147 158 169 180

eGFR (Spotchem) ()

1

2

3

MQ 2015/1 Page 64/181

Page 65: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

HbA1c sample A

K3 HbA1c

QUALAB tolerance : 9 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b101 25 100.0 0.0 0.0 5.5 2.4 e

2 Afinion 610 99.5 0.2 0.3 5.7 2.8 e

3 Eurolyser 12 100.0 0.0 0.0 5.5 3.8 e*

4 Hemocue HbA1c 501 10 70.0 20.0 10.0 5.6 6.9 e*

5 NycoCard 108 86.1 6.5 7.4 5.8 5.5 e

6 DCA2000/Vantage 224 99.2 0.4 0.4 5.5 2.8 e

7 Others 10 100.0 0.0 0.0 5.6 4.0 e*

8 HPLC 6 83.3 16.7 0.0 5.6 5.4 e*

9 Roche, Cobas 20 90.0 5.0 5.0 5.6 4.3 e

4.50 4.75 5.00 5.25 5.50 5.75 6.00 6.25 6.50 6.75 7.00

HbA1c sample A (%)

1

2

3

4

5

6

7

8

9

MQ 2015/1 Page 65/181

Page 66: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

HbA1c sample B

K3 HbA1c

QUALAB tolerance : 9 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b101 21 100.0 0.0 0.0 5.8 2.9 e

2 Afinion 556 98.9 0.7 0.4 5.9 2.9 e

3 Eurolyser 10 100.0 0.0 0.0 5.7 3.5 e*

4 A1c Now 5 80.0 20.0 0.0 5.9 7.6 e*

5 Hemocue HbA1c 501 11 81.8 0.0 18.2 5.9 4.8 e*

6 NycoCard 116 76.8 10.3 12.9 5.9 5.5 e

7 DCA2000/Vantage 192 98.5 0.5 1.0 5.7 2.9 e

8 Others 7 100.0 0.0 0.0 5.6 4.1 e*

9 Roche, Cobas 15 100.0 0.0 0.0 5.7 3.3 e

5.0 5.2 5.4 5.6 5.8 6.0 6.2 6.4 6.6 6.8 7.0

HbA1c sample B (%)

1

2

3

4

5

6

7

8

9

MQ 2015/1 Page 66/181

Page 67: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

pCO2

K4 Blood gases

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b121/123/221 17 100.0 0.0 0.0 5.77 3.2 e

2 iStat 37 100.0 0.0 0.0 4.98 3.4 e

3 EPOC 22 81.8 9.1 9.1 5.04 7.4 e

4.0 4.3 4.6 4.9 5.2 5.5 5.8 6.1 6.4 6.7 7.0

pCO2 (kPa)

1

2

3

MQ 2015/1 Page 67/181

Page 68: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

pO2

K4 Blood gases

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b121/123/221 14 100.0 0.0 0.0 15.49 5.5 e

2 iStat 36 86.1 11.1 2.8 15.07 7.8 e

3 EPOC 22 81.9 4.5 13.6 14.20 7.2 e

11.0 11.8 12.6 13.4 14.2 15.0 15.8 16.6 17.4 18.2 19.0

pO2 (kPa)

1

2

3

MQ 2015/1 Page 68/181

Page 69: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

pH

K4 Blood gases

QUALAB tolerance : 1 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b121/123/221 16 100.0 0.0 0.0 7.40 0.2 e

2 iStat 37 100.0 0.0 0.0 7.43 0.1 e

3 EPOC 22 95.5 4.5 0.0 7.39 0.3 e

7.300 7.321 7.342 7.363 7.384 7.405 7.426 7.447 7.468 7.489 7.510

pH ()

1

2

3

MQ 2015/1 Page 69/181

Page 70: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Glucose BG

K4 Blood gases

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b121/123/221 5 60.0 40.0 0.0 5.6 9.5 e*

2 iStat 13 100.0 0.0 0.0 5.4 1.8 e

3 EPOC 16 100.0 0.0 0.0 5.6 2.8 e

4.5 4.7 4.9 5.1 5.3 5.5 5.7 5.9 6.1 6.3 6.5

Glucose BG (mmol/l)

1

2

3

MQ 2015/1 Page 70/181

Page 71: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Potassium BG

K4 Blood gases

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b121/123/221 15 100.0 0.0 0.0 3.8 1.0 e

2 iStat 20 100.0 0.0 0.0 3.8 1.3 e

3 EPOC 20 100.0 0.0 0.0 3.7 1.4 e

3.40 3.47 3.54 3.61 3.68 3.75 3.82 3.89 3.96 4.03 4.10

Potassium BG (mmol/l)

1

2

3

MQ 2015/1 Page 71/181

Page 72: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Sodium BG

K4 Blood gases

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b121/123/221 16 100.0 0.0 0.0 139.6 1.9 e

2 iStat 20 100.0 0.0 0.0 143.8 0.5 e

3 EPOC 19 100.0 0.0 0.0 138.2 1.0 e

125 128 131 134 137 140 143 146 149 152 155

Sodium BG (mmol/l)

1

2

3

MQ 2015/1 Page 72/181

Page 73: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Chlorid-BG

K4 Blood gases

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b121/123/221 6 100.0 0.0 0.0 97.1 2.4 e*

90.0 91.5 93.0 94.5 96.0 97.5 99.0 100.5 102.0 103.5 105.0

Chlorid-BG (mmol/l)

1

MQ 2015/1 Page 73/181

Page 74: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Calcium-BG

K4 Blood gases

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b121/123/221 11 90.9 0.0 9.1 0.51 6.7 e*

2 iStat 12 100.0 0.0 0.0 0.47 1.1 e

3 EPOC 20 95.0 0.0 5.0 0.47 3.0 e

0.40 0.42 0.44 0.46 0.48 0.50 0.52 0.54 0.56 0.58 0.60

Calcium-BG (mmol/l)

1

2

3

MQ 2015/1 Page 74/181

Page 75: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Lactate-BG

K4 Blood gases

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b121/123/221 5 60.0 40.0 0.0 1.90 6.8 e*

2 EPOC 20 95.0 5.0 0.0 1.62 4.9 e

3 iStat 7 100.0 0.0 0.0 1.63 2.2 e

1.40 1.48 1.56 1.64 1.72 1.80 1.88 1.96 2.04 2.12 2.20

Lactate-BG (mmol/l)

1

2

3

MQ 2015/1 Page 75/181

Page 76: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Calcium - Urine

U1 Urine quant.

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 13 100.0 0.0 0.0 2.11 2.5 e

1.80 1.86 1.92 1.98 2.04 2.10 2.16 2.22 2.28 2.34 2.40

Calcium - Urine (mmol/l)

1

MQ 2015/1 Page 76/181

Page 77: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Chloride - Urine

U1 Urine quant.

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 4 100.0 0.0 0.0 127 1.5 e*

2 ISE 5 100.0 0.0 0.0 138 1.9 a

115.0 118.5 122.0 125.5 129.0 132.5 136.0 139.5 143.0 146.5 150.0

Chloride - Urine (mmol/l)

1

2

MQ 2015/1 Page 77/181

Page 78: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Glucose - Urine

U1 Urine quant.

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 12 100.0 0.0 0.0 6.6 3.0 e

5.80 5.96 6.12 6.28 6.44 6.60 6.76 6.92 7.08 7.24 7.40

Glucose - Urine (mmol/l)

1

MQ 2015/1 Page 78/181

Page 79: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Magnesium - Urine

U1 Urine quant.

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 8 100.0 0.0 0.0 2.9 4.6 e*

2.50 2.59 2.68 2.77 2.86 2.95 3.04 3.13 3.22 3.31 3.40

Magnesium - Urine (mmol/l)

1

MQ 2015/1 Page 79/181

Page 80: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Osmolality - Urine

U1 Urine quant.

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cryoskopy 6 100.0 0.0 0.0 565 0.3 e

500 515 530 545 560 575 590 605 620 635 650

Osmolality - Urine (mosm/kg)

1

MQ 2015/1 Page 80/181

Page 81: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Phosphate - Urine

U1 Urine quant.

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 14 100.0 0.0 0.0 10.8 4.3 e

8.50 8.95 9.40 9.85 10.30 10.75 11.20 11.65 12.10 12.55 13.00

Phosphate - Urine (mmol/l)

1

MQ 2015/1 Page 81/181

Page 82: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Potassium - Urine

U1 Urine quant.

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 18 100.0 0.0 0.0 45 3.2 e

35 37 39 41 43 45 47 49 51 53 55

Potassium - Urine (mmol/l)

1

MQ 2015/1 Page 82/181

Page 83: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

total Protein - Urine

U1 Urine quant.

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas/Roche 12 100.0 0.0 0.0 286.6 6.2 e

2 Other methods 4 100.0 0.0 0.0 347.5 11.1 e*

200 225 250 275 300 325 350 375 400 425 450

total Protein - Urine (mg/l)

1

2

MQ 2015/1 Page 83/181

Page 84: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Sodium - Urine

U1 Urine quant.

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 17 100.0 0.0 0.0 110 1.8 e

90 94 98 102 106 110 114 118 122 126 130

Sodium - Urine (mmol/l)

1

MQ 2015/1 Page 84/181

Page 85: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Urea - Urine

U1 Urine quant.

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 14 100.0 0.0 0.0 189 4.9 e

150 158 166 174 182 190 198 206 214 222 230

Urea - Urine (mmol/l)

1

MQ 2015/1 Page 85/181

Page 86: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Uric Acid - Urine

U1 Urine quant.

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Standard chemistry 13 100.0 0.0 0.0 0.79 5.8 e

0.65 0.68 0.71 0.74 0.77 0.80 0.83 0.86 0.89 0.92 0.95

Uric Acid - Urine (mmol/l)

1

MQ 2015/1 Page 86/181

Page 87: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Specific Gravity - Urine

U1 Urine quant.

QUALAB tolerance : 5 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Refractometer 6 100.0 0.0 0.0 1.017 0.2 a

0.950 0.963 0.976 0.989 1.002 1.015 1.028 1.041 1.054 1.067 1.080

Specific Gravity - Urine ()

1

MQ 2015/1 Page 87/181

Page 88: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

INR

G1 Coagulation INR

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Thromborel S 4 75.0 25.0 0.0 1.62 12.4 e*

2 Neoplastin Plus 5 100.0 0.0 0.0 2.01 4.2 e*

3 Innovin 16 93.7 0.0 6.3 1.63 2.8 e

4 Recombiplastin IL 5 100.0 0.0 0.0 1.68 4.5 e*

5 Other methods 5 80.0 20.0 0.0 1.70 11.0 e*

6 Neoplastin R 9 100.0 0.0 0.0 1.70 5.5 e*

1.30 1.41 1.52 1.63 1.74 1.85 1.96 2.07 2.18 2.29 2.40

INR ()

1

2

3

4

5

6

MQ 2015/1 Page 88/181

Page 89: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Fibrinogen OA

G1 Coagulation INR

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Other methods 11 90.9 9.1 0.0 0.99 10.2 e*

2 Siemens Thrombin 4 100.0 0.0 0.0 1.01 8.2 e*

3 Stago/STA 7 100.0 0.0 0.0 1.10 4.9 e*

0.80 0.85 0.90 0.95 1.00 1.05 1.10 1.15 1.20 1.25 1.30

Fibrinogen OA (g/l)

1

2

3

MQ 2015/1 Page 89/181

Page 90: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Activated Prothrombin Time

G1 Coagulation INR

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Other methods 15 100.0 0.0 0.0 44.1 9.5 e

2 Actin FS 8 75.0 25.0 0.0 42.8 14.6 e*

3 Stago/STA 6 100.0 0.0 0.0 49.6 4.0 e

30 34 38 42 46 50 54 58 62 66 70

Activated Prothrombin Time (Sek)

1

2

3

MQ 2015/1 Page 90/181

Page 91: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Prothrombin time NT

G3 Coagulation NT

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Neoplastin R 6 100.0 0.0 0.0 96 1.1 e

2 Innovin 9 100.0 0.0 0.0 96 5.3 e

3 all Participants 5 100.0 0.0 0.0 100 4.2 e*

4 Recombiplastin IL 6 100.0 0.0 0.0 100 0.0 e

75 80 85 90 95 100 105 110 115 120 125

Prothrombin time NT (%)

1

2

3

4

MQ 2015/1 Page 91/181

Page 92: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Fibrinogen N

G3 Coagulation NT

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Siemens Thrombin 4 100.0 0.0 0.0 2.32 6.5 e*

2 Other methods 12 100.0 0.0 0.0 2.40 7.1 e*

3 Stago/STA 8 100.0 0.0 0.0 2.70 3.8 e

1.90 2.05 2.20 2.35 2.50 2.65 2.80 2.95 3.10 3.25 3.40

Fibrinogen N (g/l)

1

2

3

MQ 2015/1 Page 92/181

Page 93: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

aPTT N

G3 Coagulation NT

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Actin FS 9 100.0 0.0 0.0 27.0 6.3 e

2 Other methods 13 100.0 0.0 0.0 27.0 8.7 e

3 Stago/STA 6 100.0 0.0 0.0 32.3 5.0 e

15 18 21 24 27 30 33 36 39 42 45

aPTT N (Sek)

1

2

3

MQ 2015/1 Page 93/181

Page 94: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Prothrombin time HT

G4 Coagulation heparine

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Neoplastin R 6 100.0 0.0 0.0 97 1.5 e

2 Innovin 8 100.0 0.0 0.0 92 6.6 e*

3 Recombiplastin IL 5 100.0 0.0 0.0 100 0.9 e

70 75 80 85 90 95 100 105 110 115 120

Prothrombin time HT (%)

1

2

3

MQ 2015/1 Page 94/181

Page 95: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Fibrinogen H

G4 Coagulation heparine

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Siemens Thrombin 4 75.0 0.0 25.0 2.97 6.5 e*

2 Other methods 10 100.0 0.0 0.0 3.11 5.4 e

3 Stago/STA 6 100.0 0.0 0.0 3.31 3.0 e

2.40 2.55 2.70 2.85 3.00 3.15 3.30 3.45 3.60 3.75 3.90

Fibrinogen H (g/l)

1

2

3

MQ 2015/1 Page 95/181

Page 96: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

aPTT H

G4 Coagulation heparine

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Actin FS 7 100.0 0.0 0.0 60.8 9.5 e*

2 Other methods 10 80.0 20.0 0.0 72.9 16.9 e*

3 Stago/STA 4 100.0 0.0 0.0 86.1 18.5 e*

40 48 56 64 72 80 88 96 104 112 120

aPTT H (Sek)

1

2

3

MQ 2015/1 Page 96/181

Page 97: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Troponin I

K5 Cardiac Markers

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Vidas 6 100.0 0.0 0.0 15.6 5.7 e

2 AQT 90 FLEX 5 100.0 0.0 0.0 0.7 6.4 e

3 ADVIA Centaur XP/CP 6 100.0 0.0 0.0 4.4 12.1 e*

4 Eurolyser 11 45.4 9.1 45.5 3.0 18.8 e*

0.0 2.1 4.2 6.3 8.4 10.5 12.6 14.7 16.8 18.9 21.0

Troponin I (µg/l)

1

2

3

4

MQ 2015/1 Page 97/181

Page 98: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Troponin T

K5 Cardiac Markers

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas hs 5 100.0 0.0 0.0 1.99 12.1 e*

2 Cobas hs STAT 5 100.0 0.0 0.0 2.02 1.0 e

1.40 1.52 1.64 1.76 1.88 2.00 2.12 2.24 2.36 2.48 2.60

Troponin T (µg/l)

1

2

MQ 2015/1 Page 98/181

Page 99: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Myoglobin

K5 Cardiac Markers

QUALAB tolerance : 30 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 350.5 3.8 e

200 230 260 290 320 350 380 410 440 470 500

Myoglobin (µg/l)

1

MQ 2015/1 Page 99/181

Page 100: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

D-dimer

G6 D-dimer

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas (Zitratplasma) 4 100.0 0.0 0.0 1.50 1.8 e

2 STA Liatest 7 100.0 0.0 0.0 1.47 4.1 e

3 Eurolyser 20 85.0 0.0 15.0 0.68 10.3 e

4 ACL 4 100.0 0.0 0.0 2.21 5.1 e*

5 AQT 90 FLEX 6 100.0 0.0 0.0 0.84 7.1 e*

6 Vidas 10 100.0 0.0 0.0 1.48 8.6 e*

0.0 0.3 0.6 0.9 1.2 1.5 1.8 2.1 2.4 2.7 3.0

D-dimer (mg/l)

1

2

3

4

5

6

MQ 2015/1 Page 100/181

Page 101: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

D-Dimer NC

G5 D-Dimer NC

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 NycoCard 50 62.0 0.0 38.0 0.50 14.9 e

0.35 0.38 0.41 0.44 0.47 0.50 0.53 0.56 0.59 0.62 0.65

D-Dimer NC (mg/l)

1

MQ 2015/1 Page 101/181

Page 102: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

TSH

K6 Hormones

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas E / Elecsys 10 100.0 0.0 0.0 12.0 3.0 e

2 ADVIA Centaur XP/CP 5 100.0 0.0 0.0 10.3 4.9 e

3 Architect 7 100.0 0.0 0.0 10.2 2.8 e

4 Vidas 9 100.0 0.0 0.0 12.5 6.6 e

5 Other methods 4 75.0 0.0 25.0 10.0 14.1 e*

6 Qualigen 4 75.0 25.0 0.0 8.9 12.5 e*

6 7 8 9 10 11 12 13 14 15 16

TSH (mU/l)

1

2

3

4

5

6

MQ 2015/1 Page 102/181

Page 103: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

T3

K6 Hormones

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas E / Elecsys 4 100.0 0.0 0.0 3.4 1.6 e

2.50 2.66 2.82 2.98 3.14 3.30 3.46 3.62 3.78 3.94 4.10

T3 (nmol/l)

1

MQ 2015/1 Page 103/181

Page 104: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

FT3

K6 Hormones

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas E / Elecsys 10 100.0 0.0 0.0 11.3 3.7 e

2 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 9.1 2.3 e

3 Architect 6 100.0 0.0 0.0 8.4 6.5 e*

4 Vidas 4 100.0 0.0 0.0 10.2 7.8 e*

6.0 6.8 7.6 8.4 9.2 10.0 10.8 11.6 12.4 13.2 14.0

FT3 (pmol/l)

1

2

3

4

MQ 2015/1 Page 104/181

Page 105: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

FT4

K6 Hormones

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas E / Elecsys 11 100.0 0.0 0.0 34.5 3.9 e

2 ADVIA Centaur XP 4 100.0 0.0 0.0 23.7 6.6 e*

3 Architect 7 100.0 0.0 0.0 28.9 4.3 e

4 Vidas 6 100.0 0.0 0.0 33.2 3.9 e

5 Other methods 4 100.0 0.0 0.0 30.7 9.6 e*

15 18 21 24 27 30 33 36 39 42 45

FT4 (pmol/l)

1

2

3

4

5

MQ 2015/1 Page 105/181

Page 106: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Cortisol

K6 Hormones

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas E / Elecsys 6 100.0 0.0 0.0 651 4.3 e

2 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 571 10.2 e*

400 440 480 520 560 600 640 680 720 760 800

Cortisol (nmol/l)

1

2

MQ 2015/1 Page 106/181

Page 107: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Luteinizing hormone

K6 Hormones

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 32.0 8.5 e*

20.0 22.1 24.2 26.3 28.4 30.5 32.6 34.7 36.8 38.9 41.0

Luteinizing hormone (U/l)

1

MQ 2015/1 Page 107/181

Page 108: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Follicle-stimulating hormone

K6 Hormones

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 24.6 9.8 e*

18.0 19.5 21.0 22.5 24.0 25.5 27.0 28.5 30.0 31.5 33.0

Follicle-stimulating hormone (U/l)

1

MQ 2015/1 Page 108/181

Page 109: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Prolactine

K6 Hormones

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 19.6 12.2 e*

14.0 15.1 16.2 17.3 18.4 19.5 20.6 21.7 22.8 23.9 25.0

Prolactine (µg/l)

1

MQ 2015/1 Page 109/181

Page 110: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Troponin T CR

K8 Cardiac Reader/h232

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas h 232 746 97.4 1.9 0.7 0.29 9.5 e

2 Cardiac Reader 67 83.6 14.9 1.5 0.29 14.1 e

0.15 0.18 0.21 0.24 0.27 0.30 0.33 0.36 0.39 0.42 0.45

Troponin T CR (µg/l)

1

2

MQ 2015/1 Page 110/181

Page 111: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Troponin I WB

K8 Cardiac Reader/h232

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 iStat 4 100.0 0.0 0.0 6.19 9.9 e*

4.0 4.4 4.8 5.2 5.6 6.0 6.4 6.8 7.2 7.6 8.0

Troponin I WB (µg/l)

1

MQ 2015/1 Page 111/181

Page 112: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Myoglobin CR

K8 Cardiac Reader/h232

QUALAB tolerance : 30 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas h 232 4 100.0 0.0 0.0 700.0 0.0 e

400 460 520 580 640 700 760 820 880 940 1000

Myoglobin CR (µg/l)

1

MQ 2015/1 Page 112/181

Page 113: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

D-dimer CR

K8 Cardiac Reader/h232

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas h 232 766 96.7 2.1 1.2 0.13 14.9 a

2 Cardiac Reader 60 98.3 1.7 0.0 0.14 15.0 a

0.080 0.092 0.104 0.116 0.128 0.140 0.152 0.164 0.176 0.188 0.200

D-dimer CR (mg/l)

1

2

MQ 2015/1 Page 113/181

Page 114: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

CKMB - K8

K8 Cardiac Reader/h232

QUALAB tolerance : 40 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas h 232 7 100.0 0.0 0.0 7.5 6.9 e

4.0 4.7 5.4 6.1 6.8 7.5 8.2 8.9 9.6 10.3 11.0

CKMB - K8 (µg/l)

1

MQ 2015/1 Page 114/181

Page 115: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

NT-proBNP CR

K8 Cardiac Reader/h232

QUALAB tolerance : 27 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas h 232 478 95.4 3.6 1.0 915 12.0 e

2 Cardiac Reader 22 81.8 9.1 9.1 915 13.8 e

500 580 660 740 820 900 980 1060 1140 1220 1300

NT-proBNP CR (ng/l)

1

2

MQ 2015/1 Page 115/181

Page 116: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

PCO2 CCA

K9 Blood Gases AVL Opti CCA

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 OPTI CCA 14 100.0 0.0 0.0 5.85 4.6 e

5.00 5.17 5.34 5.51 5.68 5.85 6.02 6.19 6.36 6.53 6.70

PCO2 CCA (kPa)

1

MQ 2015/1 Page 116/181

Page 117: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

PO2 CCA

K9 Blood Gases AVL Opti CCA

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 OPTI CCA 14 92.9 0.0 7.1 14.16 7.3 e*

11.0 11.6 12.2 12.8 13.4 14.0 14.6 15.2 15.8 16.4 17.0

PO2 CCA (kPa)

1

MQ 2015/1 Page 117/181

Page 118: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

pH CCA

K9 Blood Gases AVL Opti CCA

QUALAB tolerance : 1 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 OPTI CCA 14 100.0 0.0 0.0 7.42 0.2 e

7.340 7.355 7.370 7.385 7.400 7.415 7.430 7.445 7.460 7.475 7.490

pH CCA ()

1

MQ 2015/1 Page 118/181

Page 119: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Potassium CCA

K9 Blood Gases AVL Opti CCA

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 OPTI CCA 8 100.0 0.0 0.0 4.7 1.1 e

4.30 4.38 4.46 4.54 4.62 4.70 4.78 4.86 4.94 5.02 5.10

Potassium CCA (mmol/l)

1

MQ 2015/1 Page 119/181

Page 120: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Sodium CCA

K9 Blood Gases AVL Opti CCA

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 OPTI CCA 7 100.0 0.0 0.0 144.0 0.8 e

134 136 138 140 142 144 146 148 150 152 154

Sodium CCA (mmol/l)

1

MQ 2015/1 Page 120/181

Page 121: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Ferritin

K10 Anemia

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 5 80.0 0.0 20.0 202.00 14.0 e*

2 Cobas E / Elecsys 11 100.0 0.0 0.0 196.51 8.5 e

3 Architect 4 100.0 0.0 0.0 246.85 5.0 e

4 Mira/DiaSys 4 100.0 0.0 0.0 173.00 7.4 e*

5 Mini Vidas 4 100.0 0.0 0.0 176.75 4.6 e

6 Eurolyser 22 86.4 13.6 0.0 140.30 17.1 e*

80 105 130 155 180 205 230 255 280 305 330

Ferritin (µg/l)

1

2

3

4

5

6

MQ 2015/1 Page 121/181

Page 122: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Vitamin B12

K10 Anemia

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ADVIA Centaur XP/CP 5 80.0 20.0 0.0 350.00 13.2 e*

2 Cobas E / Elecsys 7 100.0 0.0 0.0 366.00 1.9 e

3 Architect 5 100.0 0.0 0.0 355.00 6.7 e*

250 271 292 313 334 355 376 397 418 439 460

Vitamin B12 (pmol/l)

1

2

3

MQ 2015/1 Page 122/181

Page 123: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Folate

K10 Anemia

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ADVIA Centaur XP 4 100.0 0.0 0.0 10.20 9.7 e*

2 Cobas E / Elecsys 7 100.0 0.0 0.0 15.27 6.0 e

3 Architect 5 80.0 20.0 0.0 16.77 11.6 e*

7.0 8.5 10.0 11.5 13.0 14.5 16.0 17.5 19.0 20.5 22.0

Folate (nmol/l)

1

2

3

MQ 2015/1 Page 123/181

Page 124: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

BNP

K11 BNP

QUALAB tolerance : 27 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Triage Meter 42 92.8 2.4 4.8 341.3 14.4 e

200 225 250 275 300 325 350 375 400 425 450

BNP (ng/l)

1

MQ 2015/1 Page 124/181

Page 125: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

G10 INR INRatio

INR INRatio University Hospital Zuerich

INRatio Participants

G10 is a split-sample survey. We compare INR-values from our participans with the corresponding plasma INR from University Hospital Zuerich. Nr. Device Total % good % insufficient % outlier

1 INRatio 63 90.48 1.59 7.94

MQ 2015/1 Seite 125/181

Page 126: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Bilirubin total Neo

K12 Neonatal Bilirubin

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 11 100.0 0.0 0.0 98 5.9 e

75 80 85 90 95 100 105 110 115 120 125

Bilirubin total Neo (µmol/l)

1

MQ 2015/1 Page 126/181

Page 127: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Bilirubin direct

K12 Neonatal Bilirubin

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 13 92.3 0.0 7.7 50 7.0 e

39.0 41.1 43.2 45.3 47.4 49.5 51.6 53.7 55.8 57.9 60.0

Bilirubin direct (µmol/l)

1

MQ 2015/1 Page 127/181

Page 128: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Bilirubin neonatal

K12 Neonatal Bilirubin

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 6 83.3 16.7 0.0 136 10.3 e*

100 107 114 121 128 135 142 149 156 163 170

Bilirubin neonatal (µmol/l)

1

MQ 2015/1 Page 128/181

Page 129: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

CK-MB

K15 Creatinkinase Activity

QUALAB tolerance : 30 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Fuji Dri-Chem 41 95.1 0.0 4.9 52.7 6.9 e

30.0 34.5 39.0 43.5 48.0 52.5 57.0 61.5 66.0 70.5 75.0

CK-MB (U/l)

1

MQ 2015/1 Page 129/181

Page 130: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

PSA

K14 Tumor Markers

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas E / Elecsys 9 100.0 0.0 0.0 4.50 2.0 e

2 ADVIA Centaur XP/CP 5 100.0 0.0 0.0 3.40 4.4 e

3 Architect 5 100.0 0.0 0.0 3.79 2.6 e

4 Qualigen 5 100.0 0.0 0.0 4.70 8.0 e*

2.00 2.45 2.90 3.35 3.80 4.25 4.70 5.15 5.60 6.05 6.50

PSA (µg/l)

1

2

3

4

MQ 2015/1 Page 130/181

Page 131: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

free PSA

K14 Tumor Markers

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas E / Elecsys 5 100.0 0.0 0.0 1.00 5.3 e

2 Architect 4 100.0 0.0 0.0 0.83 5.6 e

0.50 0.58 0.66 0.74 0.82 0.90 0.98 1.06 1.14 1.22 1.30

free PSA (µg/l)

1

2

MQ 2015/1 Page 131/181

Page 132: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

CEA

K14 Tumor Markers

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas E / Elecsys 5 100.0 0.0 0.0 22.5 6.5 e

2 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 32.6 2.4 e

3 Architect 4 100.0 0.0 0.0 34.6 6.6 e*

10 14 18 22 26 30 34 38 42 46 50

CEA (µg/l)

1

2

3

MQ 2015/1 Page 132/181

Page 133: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

CA 125

K14 Tumor Markers

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Architect 4 100.0 0.0 0.0 204.8 6.3 e*

140 153 166 179 192 205 218 231 244 257 270

CA 125 (kIU/l)

1

MQ 2015/1 Page 133/181

Page 134: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

CA 15-3

K14 Tumor Markers

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Architect 4 100.0 0.0 0.0 20.4 3.9 e

14.0 15.3 16.6 17.9 19.2 20.5 21.8 23.1 24.4 25.7 27.0

CA 15-3 (kIU/l)

1

MQ 2015/1 Page 134/181

Page 135: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

HCG qn

K14 Tumor Markers

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas E / Elecsys 5 100.0 0.0 0.0 17 6.8 e*

2 ADVIA Centaur XP/CP 4 100.0 0.0 0.0 9 11.0 e*

3 Vidas 4 100.0 0.0 0.0 2 6.7 e*

0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0

HCG qn (U/l)

1

2

3

MQ 2015/1 Page 135/181

Page 136: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

pH OR

K16 Blood Gases Radiometer

QUALAB tolerance : 1 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 80 100.0 0.0 0.0 7.40 0.1 e

2 Radiometer NPT-7 6 100.0 0.0 0.0 7.43 0.2 e

3 ABL 90 24 100.0 0.0 0.0 7.40 0.1 e

4 ABL 80 / Coox 13 100.0 0.0 0.0 7.40 0.3 e

5 ABL 5 6 100.0 0.0 0.0 7.40 0.0 e

7.30 7.32 7.34 7.36 7.38 7.40 7.42 7.44 7.46 7.48 7.50

pH OR ()

1

2

3

4

5

MQ 2015/1 Page 136/181

Page 137: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

pCO2 OR

K16 Blood Gases Radiometer

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 79 98.7 1.3 0.0 5.38 2.6 e

2 Radiometer NPT-7 6 100.0 0.0 0.0 5.79 2.5 e

3 ABL 90 24 100.0 0.0 0.0 5.51 1.9 e

4 ABL 80 / Coox 13 100.0 0.0 0.0 5.70 6.3 e*

5 ABL 5 6 100.0 0.0 0.0 5.48 1.2 e

4.50 4.75 5.00 5.25 5.50 5.75 6.00 6.25 6.50 6.75 7.00

pCO2 OR (kPa)

1

2

3

4

5

MQ 2015/1 Page 137/181

Page 138: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

pO2 OR

K16 Blood Gases Radiometer

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 80 97.5 2.5 0.0 15.15 4.9 e

2 Radiometer NPT-7 6 100.0 0.0 0.0 14.36 2.9 e

3 ABL 90 24 91.6 4.2 4.2 13.52 5.8 e

4 ABL 80 / Coox 13 92.3 0.0 7.7 13.91 7.5 e*

5 ABL 5 6 100.0 0.0 0.0 14.10 3.6 e

10 11 12 13 14 15 16 17 18 19 20

pO2 OR (kPa)

1

2

3

4

5

MQ 2015/1 Page 138/181

Page 139: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

ctHb OR

K16 Blood Gases Radiometer

QUALAB tolerance : 9 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 72 79.2 0.0 20.8 131.0 1.6 a

2 Radiometer NPT-7 4 75.0 0.0 25.0 200.5 1.4 e

3 ABL 90 22 100.0 0.0 0.0 129.9 0.9 e

4 ABL 80 / Coox 9 100.0 0.0 0.0 130.0 1.6 e

100 115 130 145 160 175 190 205 220 235 250

ctHb OR (g/l)

1

2

3

4

MQ 2015/1 Page 139/181

Page 140: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

sO2 OR

K16 Blood Gases Radiometer

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 54 100.0 0.0 0.0 97.223 0.2 e

2 ABL 90 22 100.0 0.0 0.0 97.168 0.1 e

3 ABL 80 / Coox 9 100.0 0.0 0.0 97.200 0.4 e

70 75 80 85 90 95 100 105 110 115 120

sO2 OR (%)

1

2

3

MQ 2015/1 Page 140/181

Page 141: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

FO2Hb OR

K16 Blood Gases Radiometer

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 50 100.0 0.0 0.0 91.988 0.2 e

2 Radiometer NPT-7 5 80.0 0.0 20.0 49.000 0.0 e

3 ABL 90 22 100.0 0.0 0.0 92.150 0.1 e

4 ABL 80 / Coox 9 100.0 0.0 0.0 92.200 0.1 e

30 39 48 57 66 75 84 93 102 111 120

FO2Hb OR (%)

1

2

3

4

MQ 2015/1 Page 141/181

Page 142: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

FCOHb OR

K16 Blood Gases Radiometer

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 51 96.1 3.9 0.0 3.394 8.8 e

2 Radiometer NPT-7 5 80.0 0.0 20.0 20.000 0.2 e

3 ABL 90 22 100.0 0.0 0.0 3.200 4.3 e

4 ABL 80 / Coox 9 88.9 0.0 11.1 3.200 5.5 e

0 3 6 9 12 15 18 21 24 27 30

FCOHb OR (%)

1

2

3

4

MQ 2015/1 Page 142/181

Page 143: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

FMetHb OR

K16 Blood Gases Radiometer

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 52 94.3 3.8 1.9 1.986 6.2 e

2 Radiometer NPT-7 5 80.0 0.0 20.0 10.000 0.0 e

3 ABL 90 22 95.5 0.0 4.5 1.924 2.8 e

4 ABL 80 / Coox 9 100.0 0.0 0.0 2.000 6.3 e

0.0 1.5 3.0 4.5 6.0 7.5 9.0 10.5 12.0 13.5 15.0

FMetHb OR (%)

1

2

3

4

MQ 2015/1 Page 143/181

Page 144: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

FHbF OR

K16 Blood Gases Radiometer

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL 90 6 100.0 0.0 0.0 84.000 1.8 e

2 ABL 80 / Coox 4 100.0 0.0 0.0 2.550 5.1 e*

0 11 22 33 44 55 66 77 88 99 110

FHbF OR (%)

1

2

MQ 2015/1 Page 144/181

Page 145: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Bilirubin OR

K16 Blood Gases Radiometer

QUALAB tolerance : 18 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 8 100.0 0.0 0.0 303.5 1.0 e

2 ABL 90 9 100.0 0.0 0.0 299.0 0.8 e

230 245 260 275 290 305 320 335 350 365 380

Bilirubin OR (µmol/l)

1

2

MQ 2015/1 Page 145/181

Page 146: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Potassium OR

K16 Blood Gases Radiometer

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 66 100.0 0.0 0.0 3.8 0.9 e

2 ABL 90 24 100.0 0.0 0.0 3.8 1.1 e

3 ABL 80 / Coox 6 100.0 0.0 0.0 3.8 0.9 e

3.50 3.56 3.62 3.68 3.74 3.80 3.86 3.92 3.98 4.04 4.10

Potassium OR (mmol/l)

1

2

3

MQ 2015/1 Page 146/181

Page 147: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Sodium OR

K16 Blood Gases Radiometer

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 65 100.0 0.0 0.0 140.4 0.6 e

2 ABL 90 24 100.0 0.0 0.0 141.3 0.4 e

3 ABL 80 / Coox 5 100.0 0.0 0.0 141.0 1.3 e

130.0 132.5 135.0 137.5 140.0 142.5 145.0 147.5 150.0 152.5 155.0

Sodium OR (mmol/l)

1

2

3

MQ 2015/1 Page 147/181

Page 148: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Calcium OR

K16 Blood Gases Radiometer

QUALAB tolerance : 12 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 66 100.0 0.0 0.0 0.54 3.1 e

2 ABL 90 24 95.8 0.0 4.2 0.53 1.0 e

3 ABL 80 / Coox 5 100.0 0.0 0.0 0.52 2.9 e

0.450 0.466 0.482 0.498 0.514 0.530 0.546 0.562 0.578 0.594 0.610

Calcium OR (mmol/l)

1

2

3

MQ 2015/1 Page 148/181

Page 149: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Choride OR

K16 Blood Gases Radiometer

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 56 100.0 0.0 0.0 97.67 1.1 e

2 ABL 90 24 100.0 0.0 0.0 97.17 0.5 e

3 ABL 80 / Coox 5 100.0 0.0 0.0 97.00 1.2 e

90.0 91.5 93.0 94.5 96.0 97.5 99.0 100.5 102.0 103.5 105.0

Choride OR (mmol/l)

1

2

3

MQ 2015/1 Page 149/181

Page 150: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Glucose OR

K16 Blood Gases Radiometer

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 67 98.5 0.0 1.5 5.8 2.1 e

2 ABL 90 24 100.0 0.0 0.0 5.7 1.9 e

5.00 5.15 5.30 5.45 5.60 5.75 5.90 6.05 6.20 6.35 6.50

Glucose OR (mmol/l)

1

2

MQ 2015/1 Page 150/181

Page 151: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Lactate OR

K16 Blood Gases Radiometer

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ABL700/800 Radiomete 69 97.2 1.4 1.4 1.70 3.1 e

2 ABL 90 24 100.0 0.0 0.0 1.65 3.9 e

1.40 1.45 1.50 1.55 1.60 1.65 1.70 1.75 1.80 1.85 1.90

Lactate OR (mmol/l)

1

2

MQ 2015/1 Page 151/181

Page 152: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

BNP Plasma

K17 BNP Plasma

QUALAB tolerance : 27 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 ADVIA Centaur XP/CP 5 100.0 0.0 0.0 519.3 3.1 e

300 340 380 420 460 500 540 580 620 660 700

BNP Plasma (ng/l)

1

MQ 2015/1 Page 152/181

Page 153: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

NT-proBNP

K17 BNP Plasma

QUALAB tolerance : 27 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 AQT 90 FLEX 5 100.0 0.0 0.0 1560.0 6.5 e

2 Cobas E / Elecsys 12 100.0 0.0 0.0 570.1 6.1 e

0 250 500 750 1000 1250 1500 1750 2000 2250 2500

NT-proBNP (ng/l)

1

2

MQ 2015/1 Page 153/181

Page 154: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Cholesterin PTS

K19 CardioChek Lipidpanel

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 CardioChek 5 60.0 40.0 0.0 7.4 9.3 e*

6.00 6.25 6.50 6.75 7.00 7.25 7.50 7.75 8.00 8.25 8.50

Cholesterin PTS (mmol/l)

1

MQ 2015/1 Page 154/181

Page 155: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Cholesterin HDL PTS

K19 CardioChek Lipidpanel

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 CardioChek 5 100.0 0.0 0.0 2.6 0.0 e

1.90 2.05 2.20 2.35 2.50 2.65 2.80 2.95 3.10 3.25 3.40

Cholesterin HDL PTS (mmol/l)

1

MQ 2015/1 Page 155/181

Page 156: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Triglyceride PTS

K19 CardioChek Lipidpanel

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 CardioChek 5 100.0 0.0 0.0 5.65 0.4 e

4.0 4.3 4.6 4.9 5.2 5.5 5.8 6.1 6.4 6.7 7.0

Triglyceride PTS (mmol/l)

1

MQ 2015/1 Page 156/181

Page 157: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Creatinine U

U5 Urine Albumin / ACR

QUALAB tolerance : 30 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Siemens Clinitek 11 72.7 9.1 18.2 80.0 13.4 a

2 Afinion 318 97.8 1.3 0.9 90.4 10.9 e

3 NycoCard 19 94.7 0.0 5.3 92.4 17.1 e*

4 Turbidimetry 13 100.0 0.0 0.0 84.2 4.8 e

5 DCA2000/Vantage 111 97.3 0.0 2.7 86.9 5.0 e

40 49 58 67 76 85 94 103 112 121 130

Creatinine U (mg/l)

1

2

3

4

5

MQ 2015/1 Page 157/181

Page 158: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Creatinin Urin

U5 Urine Albumin / ACR

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 DCA2000/Vantage 111 95.5 0.0 4.5 5.6 3.6 e

2 Afinion 318 98.8 0.6 0.6 5.0 5.7 e

3 Standard chemistry 23 100.0 0.0 0.0 5.4 5.4 e

4 Siemens Clinitek 9 66.7 0.0 33.3 8.8 5.3 e

3.0 3.8 4.6 5.4 6.2 7.0 7.8 8.6 9.4 10.2 11.0

Creatinin Urin (mmol/l)

1

2

3

4

MQ 2015/1 Page 158/181

Page 159: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

INR CCXS

G11 CoaguChek XS INR

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 CoaguChek XS 2342 98.1 1.6 0.3 2.2 4.8 e

1.50 1.62 1.74 1.86 1.98 2.10 2.22 2.34 2.46 2.58 2.70

INR CCXS ()

1

MQ 2015/1 Page 159/181

Page 160: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

INR HC

G12 Hemochron

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Hemochron j. 24 66.7 20.8 12.5 4.5 10.4 e*

3.5 3.7 3.9 4.1 4.3 4.5 4.7 4.9 5.1 5.3 5.5

INR HC ()

1

MQ 2015/1 Page 160/181

Page 161: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Osmolality

K22 Osmolality

QUALAB tolerance : 6 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cryoskopy 11 90.9 9.1 0.0 147 2.4 e*

135.0 137.5 140.0 142.5 145.0 147.5 150.0 152.5 155.0 157.5 160.0

Osmolality (mosm/kg)

1

MQ 2015/1 Page 161/181

Page 162: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Procalcitonin

K20 PCT

QUALAB tolerance : 27 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 16 100.0 0.0 0.0 2.08 10.7 e

2 Mini Vidas 10 100.0 0.0 0.0 2.87 8.8 e

1.0 1.3 1.6 1.9 2.2 2.5 2.8 3.1 3.4 3.7 4.0

Procalcitonin (µg/l)

1

2

MQ 2015/1 Page 162/181

Page 163: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Parathyroid hormone

K21 PTH / Vit. D

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas PTH STAT 5 100.0 0.0 0.0 37.4 2.0 e

25.0 27.5 30.0 32.5 35.0 37.5 40.0 42.5 45.0 47.5 50.0

Parathyroid hormone (pmol/l)

1

MQ 2015/1 Page 163/181

Page 164: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

25-OH Vitamin D

K21 PTH / Vit. D

QUALAB tolerance : 27 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Qualigen 4 100.0 0.0 0.0 160.5 6.1 e

2 Cobas 7 100.0 0.0 0.0 153.1 7.9 e

3 Architect 4 100.0 0.0 0.0 135.9 9.7 e*

90 102 114 126 138 150 162 174 186 198 210

25-OH Vitamin D (nmol/l)

1

2

3

MQ 2015/1 Page 164/181

Page 165: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Digoxin

K24 Drug Monitoring

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Other methods 11 100.0 0.0 0.0 2.62 9.4 e

1.90 2.05 2.20 2.35 2.50 2.65 2.80 2.95 3.10 3.25 3.40

Digoxin (nmol/l)

1

MQ 2015/1 Page 165/181

Page 166: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Valproat

K24 Drug Monitoring

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 5 80.0 20.0 0.0 532.0 11.8 e*

350 390 430 470 510 550 590 630 670 710 750

Valproat (µmol/l)

1

MQ 2015/1 Page 166/181

Page 167: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Hematocrit

H5 Hematology BG

QUALAB tolerance : 9 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 EPOC 4 50.0 25.0 25.0 0.32 7.5 e*

0.27 0.28 0.29 0.30 0.31 0.32 0.33 0.34 0.35 0.36 0.37

Hematocrit (l/l)

1

MQ 2015/1 Page 167/181

Page 168: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Troponin Triage

K26 Cardiac Triage

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Triage Meter 37 64.9 8.1 27.0 3.55 14.0 e

2.5 2.7 2.9 3.1 3.3 3.5 3.7 3.9 4.1 4.3 4.5

Troponin Triage (µg/l)

1

MQ 2015/1 Page 168/181

Page 169: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

D-dimer Triage

K26 Cardiac Triage

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Triage Meter 35 97.1 0.0 2.9 100.00 0.0 e

70 76 82 88 94 100 106 112 118 124 130

D-dimer Triage (ng/ml)

1

MQ 2015/1 Page 169/181

Page 170: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

CK-MB Triage

K26 Cardiac Triage

QUALAB tolerance : 40 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Triage Meter 22 90.9 0.0 9.1 3.2 14.2 e

1.50 1.85 2.20 2.55 2.90 3.25 3.60 3.95 4.30 4.65 5.00

CK-MB Triage (µg/l)

1

MQ 2015/1 Page 170/181

Page 171: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Myoglobin Triage

K26 Cardiac Triage

QUALAB tolerance : 30 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Triage Meter 20 95.0 0.0 5.0 491.3 3.3 e

300 340 380 420 460 500 540 580 620 660 700

Myoglobin Triage (µg/l)

1

MQ 2015/1 Page 171/181

Page 172: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Ethanol

K28 Ethanol

QUALAB tolerance : 25 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 all Participants 5 100.0 0.0 0.0 21.8 5.2 e

15.0 16.5 18.0 19.5 21.0 22.5 24.0 25.5 27.0 28.5 30.0

Ethanol (mmol/l)

1

MQ 2015/1 Page 172/181

Page 173: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Calprotectin

K29 Calprotectin

QUALAB tolerance : 40 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Bühlmann 7 85.7 14.3 0.0 191 29.4 e*

70 95 120 145 170 195 220 245 270 295 320

Calprotectin (µg/g)

1

MQ 2015/1 Page 173/181

Page 174: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Cholesterol total Af/b101

K30 Lipids Af / b101

QUALAB tolerance : 10 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b101 24 100.0 0.0 0.0 4.8 1.8 e

2 Afinion 224 98.7 0.9 0.4 4.9 3.5 e

4.20 4.35 4.50 4.65 4.80 4.95 5.10 5.25 5.40 5.55 5.70

Cholesterol total Af/b101 (mmol/l)

1

2

MQ 2015/1 Page 174/181

Page 175: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Cholesterol HDL Af/b101

K30 Lipids Af / b101

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b101 24 91.7 0.0 8.3 1.4 2.8 e

2 Afinion 225 92.0 0.0 8.0 1.0 4.2 e

0.70 0.81 0.92 1.03 1.14 1.25 1.36 1.47 1.58 1.69 1.80

Cholesterol HDL Af/b101 (mmol/l)

1

2

MQ 2015/1 Page 175/181

Page 176: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Tryglycerides Af/b101

K30 Lipids Af / b101

QUALAB tolerance : 20 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Cobas b101 24 100.0 0.0 0.0 1.82 1.6 e

2 Afinion 223 100.0 0.0 0.0 1.64 3.8 e

1.20 1.31 1.42 1.53 1.64 1.75 1.86 1.97 2.08 2.19 2.30

Tryglycerides Af/b101 (mmol/l)

1

2

MQ 2015/1 Page 176/181

Page 177: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

Troponin I S

K31 Samsung IB 10

QUALAB tolerance : 24 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Samsung LABGEO IB10 68 72.1 23.5 4.4 8.07 18.7 e

5.0 5.7 6.4 7.1 7.8 8.5 9.2 9.9 10.6 11.3 12.0

Troponin I S (µg/l)

1

MQ 2015/1 Page 177/181

Page 178: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

D-dimer qn S

K31 Samsung IB 10

QUALAB tolerance : 21 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Samsung LABGEO IB10 80 97.4 1.3 1.3 1.48 6.9 e

1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 2.0

D-dimer qn S (mg/l)

1

MQ 2015/1 Page 178/181

Page 179: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

NT-pro BNP S

K31 Samsung IB 10

QUALAB tolerance : 27 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Samsung LABGEO IB10 56 100.0 0.0 0.0 1984.3 11.4 e

1300 1450 1600 1750 1900 2050 2200 2350 2500 2650 2800

NT-pro BNP S (ng/l)

1

MQ 2015/1 Page 179/181

Page 180: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

INR MI

G14 MicroINR

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 microINR 64 68.7 17.2 14.1 1.8 9.8 e

1.4 1.5 1.6 1.7 1.8 1.9 2.0 2.1 2.2 2.3 2.4

INR MI ()

1

MQ 2015/1 Page 180/181

Page 181: 2015 - 1 Swelab 68 95.6 1.5 2.9 108 2.8 e 8 MS4 8 100.0 0.0 0.0 102 4.5 e* 9 Abacus Junior 12 100.0 0.0 0.0 108 3.0 e 10 Medonic 19 100.0 0.0 0.0 106 3.8 e 11 Nihon Kohden Celltac

INR Eurolyser

G15 INR Eurolyser

QUALAB tolerance : 15 %

No.Methode Total % good % insuff. % outlier Target value CV% Typ

1 Eurolyser 7 85.7 14.3 0.0 1.0 9.1 e*

0.80 0.85 0.90 0.95 1.00 1.05 1.10 1.15 1.20 1.25 1.30

INR Eurolyser ()

1

MQ 2015/1 Page 181/181